Bridgewater Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-33,699
Closed -$11M 957
2024
Q1
$11M Sell
33,699
-5,766
-15% -$1.42M 0.06% 240
2023
Q4
$7.52M Sell
39,465
-4,063
-9% -$768K 0.04% 303
2023
Q3
$8.67M Buy
43,528
+3,736
+9% +$884K 0.05% 256
2023
Q2
$11.4M Sell
39,792
-4,360
-10% -$1.21M 0.07% 181
2023
Q1
$9.57M Buy
44,152
+1,835
+4% +$358K 0.06% 209
2022
Q4
$8.7M Sell
42,317
-13,711
-24% -$3.47M 0.05% 271
2022
Q3
$15.6M Buy
56,028
+2,609
+5% +$663K 0.08% 182
2022
Q2
$10.2M Buy
53,419
+5,048
+10% +$891K 0.04% 326
2022
Q1
$10M Buy
48,371
+12,024
+33% +$1.98M 0.04% 299
2021
Q4
$6.48M Buy
36,347
+4,226
+13% +$833K 0.04% 247
2021
Q3
$6.61M Sell
32,121
-2,732
-8% -$536K 0.04% 255
2021
Q2
$6.61M Buy
+34,853
New +$5.7M 0.04% 280

Other funds holding SWAV

Bridgewater Associates's SWAV Position: Q2 2024 in Review

Bridgewater Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 33,699 shares — an estimated $11M sold.

Bridgewater Associates first reported a position in SWAV in Q2 2021 and held it in 12 quarters. The position peaked at $15.6M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Bridgewater Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bridgewater Associates sold 33,699 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $11M.
  • Bridgewater Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Bridgewater Associates's Shockwave Medical, Inc. Common Stock position peaked at $15.6M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.